arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Biomea Fusion, Inc.

BMEA Health Care Biotechnology: Pharmaceutical Preparations
$0.60
▼ -13.0% Today
as of Oct 23, 16:46 ET
Last 30 days -66.29% Sep 14 → Oct 23
$0.49 $0.85 $1.21 $1.57 $1.93 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.66
High
$0.70
Low
$0.58
Volume
$2M
Avg Vol
$1M
Mkt Cap
$96M
P/E (TTM)
—
Beta
—
52w High
$2.24
52w Low
$0.58
Div Yield
—
Shares Out
$72M

Recent Press Releases & News last 60 days · 10 items

Oct 14 · 01:02 MarketBeat
Biomea Fusion’s BMF-650 Shows Up to 6.1% Weight Loss in Early GLP-1 Study
Oct 13 · 20:08 PR GlobeNewswire
Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist
Oct 12 · 20:30 PR GlobeNewswire
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
▸ Show all 10 press releases & news Free account →

BMEA earnings at a glance

Biomea Fusion, Inc. (BMEA) is scheduled to report earnings on Tuesday, November 3, 2026 — in 11 days. Analysts expect earnings per share of -$0.21, compared with -$0.27 in the same quarter last year (+22%). The options market is pricing a move of about ±23.7% after the report, a range of roughly $0.46 to $0.74 from today's $0.60. Over its last 5 reports the stock rose the next day 4 times and fell 1, moving ±6.4% on average; after the most recent report on May 11, 2026 it moved +0.6%. That means options currently expect more movement than BMEA has typically delivered. BMEA beat the consensus EPS estimate in 3 of its last 5 reported quarters. Implied volatility is currently 201%. The share price of $0.60 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.58
$2.24
1% of range
Avg surprise (last 5)
-22.5%
Avg reaction (last 5)
-0.2%
80% positive
Latest IV / EM
201%
EM ±23.7% · $2 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.09$-0.85$-0.60$-0.36$-0.12 Actual $-1.09Actual $-1.03Actual $-0.91Actual $-0.80Est $-0.84Actual $-0.51Est $-0.59Actual $-0.27Est $-0.26Actual $-0.64Est $-0.25Actual $-0.17Est $-0.24Actual $-0.12 MarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun
Revenue vs Net Income Revenue Net income
$-33M$-27M$-21M$-15M$-9M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.12 — — — — financials
Mon May 11, 2026Mar/2026 $-0.17 $-0.24 +29.2% +78.8% +0.6% earnings
Tue Mar 24, 20268K 2026-03-24 $-0.64 $-0.25 -156.0% — +8.0% earnings
Tue Nov 4, 2025Sep/2025 $-0.27 $-0.26 -3.9% — +6.3% earnings
Tue Aug 5, 2025Jun/2025 $-0.51 $-0.59 +13.6% — +0.6% earnings
Mon May 5, 2025Mar/2025 $-0.80 $-0.84 +4.8% — -16.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.91 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.03 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.09 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026OTHER -$0.21-$0.27 +22.2%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-13M$-13M—$-21M$-21M$-30M—$-34M
Net income$-8M$-12M—$-16M$-21M$-29M—$-33M
EPS (diluted)$-0.12$-0.17—$-0.27$-0.51$-0.80—$-0.91

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$35M$45M$56M$47M$56M$36M$58M$88M
Inventory————————
Total current assets$36M$46M$58M$49M$65M$45M$68M$94M
Total assets$37M$46M$59M$55M$73M$55M$80M$110M
Long-term debt————————
Total liabilities$25M$28M$29M$40M$46M$26M$28M$34M
Total equity$12M$19M$30M$16M$28M$29M$52M$76M

Implied volatility — last 90 days

79%344%609%874%1140% Jun 07 — IV 341% · EM ±47.2%Jun 08 — IV 198% · EM ±26.1%Jun 09 — IV 316% · EM ±39.6%Jun 10 — IV 405% · EM ±47.8%Jun 15 — IV 511% · EM ±37.0%Jun 16 — IV 502% · EM ±29.7%Jun 19 — IV 288% · EM ±63.6%Jun 26 — IV 79% · EM ±15.2%Jun 29 — IV 203% · EM ±36.0%Jun 30 — IV 139% · EM ±24.0%Jul 01 — IV 176% · EM ±29.4%Jul 02 — IV 175% · EM ±28.4%Jul 03 — IV 182% · EM ±28.4%Jul 06 — IV 196% · EM ±27.2%Jul 16 — IV 1140% · EM ±47.6%Jul 27 — IV 228% · EM ±47.6%Jul 28 — IV 313% · EM ±64.0%Jul 30 — IV 377% · EM ±73.8%Jul 31 — IV 357% · EM ±68.4%Aug 03 — IV 294% · EM ±52.1%Aug 04 — IV 201% · EM ±34.6%Aug 05 — IV 380% · EM ±63.5%Aug 10 — IV 398% · EM ±55.1%Aug 12 — IV 374% · EM ±46.9%Aug 13 — IV 562% · EM ±66.4%Aug 17 — IV 355% · EM ±29.6%Aug 18 — IV 614% · EM ±44.4%Aug 19 — IV 426% · EM ±25.2%Aug 20 — IV 528% · EM ±22.1%Aug 24 — IV 143% · EM ±29.9%Aug 25 — IV 127% · EM ±26.0%Aug 26 — IV 117% · EM ±23.4%Aug 27 — IV 228% · EM ±44.6%Aug 28 — IV 128% · EM ±24.6%Aug 31 — IV 199% · EM ±35.3%Sep 01 — IV 135% · EM ±23.2%Sep 02 — IV 264% · EM ±44.2%Sep 03 — IV 291% · EM ±47.1%Sep 04 — IV 188% · EM ±29.4%Sep 07 — IV 213% · EM ±29.6%Sep 08 — IV 412% · EM ±54.4%Sep 09 — IV 260% · EM ±32.5%Sep 10 — IV 324% · EM ±38.2%Sep 11 — IV 260% · EM ±28.7%Sep 14 — IV 437% · EM ±36.5%Sep 15 — IV 461% · EM ±33.3%Sep 16 — IV 593% · EM ±35.0%Sep 17 — IV 736% · EM ±30.7%Sep 21 — IV 145% · EM ±30.3%Sep 22 — IV 166% · EM ±33.9%Sep 23 — IV 130% · EM ±26.0%Sep 24 — IV 121% · EM ±23.6%Sep 25 — IV 178% · EM ±34.1%Sep 28 — IV 262% · EM ±46.5%Sep 29 — IV 277% · EM ±47.6%Sep 30 — IV 204% · EM ±34.1%Oct 01 — IV 187% · EM ±30.3%Oct 02 — IV 187% · EM ±29.3%Oct 06 — IV 363% · EM ±48.0%Oct 07 — IV 151% · EM ±18.9%Oct 08 — IV 201% · EM ±23.7%

Sector peers

OKUR
OnKure Therapeutics, Inc.
$95M $2.52+9.6%
RLYB
Rallybio Corporation
$90M $16.64+2.6%
MIST
Milestone Pharmaceuticals Inc.
$102M $0.65-6.7%
ZSTK
ZeroStack Corp.
$104M $3.28-8.1%
ACRV
Acrivon Therapeutics, Inc.
$86M $1.73-5.2%
PMN
ProMIS Neurosciences Inc.
$84M $8.34-8.7%

BMEA earnings FAQ

When is BMEA's next earnings date?

Biomea Fusion, Inc. is expected to report on November 3, 2026.

What is BMEA's expected move for earnings?

Options currently price a move of about ±23.7%, or $0.14 per share either way from $0.60.

How does BMEA stock usually react to earnings?

Across the last 5 reports the average next-day move was ±6.4%, up 4 times and down 1 times.

What EPS are analysts expecting from Biomea Fusion, Inc.?

The consensus estimate is -$0.21 per share, versus -$0.27 a year ago.

What is BMEA's implied volatility?

BMEA's at-the-money implied volatility is about 201% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in